Fagan Associates’s Pfizer PFE Stock Holding History

Fagan Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-139,954	Closed	-$3.71M	–	135
2024 Q4	$3.71M	Sell	139,954 -2,019	-1%	-$53.6K	0.59%	50
2024 Q3	$4.11M	Buy	141,973 +134,513	+1,803%	+$3.89M	0.69%	45
2024 Q2	$209K	Buy	+7,460	New	+$209K	0.04%	112
2023 Q2	–	Sell	-61,209	Closed	-$2.5M	–	122
2023 Q1	$2.5M	Sell	61,209 -1,184	-2%	-$48.3K	0.62%	42
2022 Q4	$3.2M	Buy	62,393 +51,397	+467%	+$2.63M	0.85%	33
2022 Q3	$481K	Buy	10,996 +1	+0%	+$44	0.13%	87
2022 Q2	$576K	Buy	10,995 +202	+2%	+$10.6K	0.15%	83
2022 Q1	$559K	Sell	10,793 -598	-5%	-$31K	0.11%	95
2021 Q4	$673K	Buy	11,391 +1,606	+16%	+$94.9K	0.13%	90
2021 Q3	$421K	Buy	9,785 +1,321	+16%	+$56.8K	0.09%	96
2021 Q2	$331K	Buy	8,464 +1,085	+15%	+$42.4K	0.07%	110
2021 Q1	$267K	Buy	7,379 +975	+15%	+$35.3K	0.06%	114
2020 Q4	$236K	Buy	+6,404	New	+$236K	0.06%	110
2020 Q1	–	Sell	-6,146	Closed	-$228K	–	114
2019 Q4	$228K	Sell	6,146 -132	-2%	-$4.9K	0.07%	112
2019 Q3	$214K	Sell	6,278 -105	-2%	-$3.58K	0.08%	111
2019 Q2	$262K	Buy	6,383 +933	+17%	+$38.3K	0.11%	103
2019 Q1	$220K	Buy	5,450 +105	+2%	+$4.24K	0.09%	105
2018 Q4	$221K	Buy	5,345 +32	+0.6%	+$1.32K	0.11%	101
2018 Q3	$222K	Buy	+5,313	New	+$222K	0.09%	111
2018 Q1	–	Sell	-38,801	Closed	-$1.33K	–	107
2017 Q4	$1.33K	Buy	38,801 +382	+1%	+$13	0.54%	52
2017 Q3	$1.3M	Buy	38,419 +3,544	+10%	+$120K	0.64%	50
2017 Q2	$1.11M	Sell	34,875 -208	-0.6%	-$6.63K	0.58%	54
2017 Q1	$1.14M	Sell	35,083 -51,241	-59%	-$1.66M	0.63%	48
2016 Q4	$2.66M	Sell	86,324 -183	-0.2%	-$5.64K	1.54%	23
2016 Q3	$2.78M	Buy	86,507 +4,185	+5%	+$134K	1.7%	19
2016 Q2	$2.75M	Buy	82,322 +4,165	+5%	+$139K	1.77%	19
2016 Q1	$2.2M	Buy	+78,157	New	+$2.2M	1.46%	23
2014 Q3	–	Sell	-42,036	Closed	-$1.18M	–	89
2014 Q2	$1.18M	Sell	42,036 -194	-0.5%	-$5.46K	1.01%	34
2014 Q1	$1.29M	Buy	+42,230	New	+$1.29M	1.11%	33